Sea, UiPath, J&J Snack Foods And Other Big Gainers From Tuesday
U.S. stocks closed higher on Tuesday, with the Nasdaq Composite gaining more than 150 points. Here is the list of some big stocks recording gains in the previous session.
Salesforce To $225? Plus Mizuho Predicts $135 For VMware
Mizuho cut the price target on Salesforce, Inc. (NYSE: CRM) from $235 to $225. Mizuho analyst Gregg Moskowitz maintained the stock with a Buy rating. Salesforce shares rose 0.9% to $160.06 in pre-market trading.
PDS Biotechnology To Rally Around 129%? Here Are 5 Other Price Target Changes For Tuesday
Chardan Capital raised PDS Biotechnology Corporation (NASDAQ:PDSB) price target from $15 to $16. . Chardan Capital analyst Geulah…
Intellia Therapeutics To Rally Around 143%? Plus Stifel Cuts PT On This Stock By 94%
Chardan Capital boosted the price target on Intellia Therapeutics, Inc. (NASDAQ: NTLA) from $121 to $129. Intellia Therapeutics shares fell 3% to close at $53.30 on Monday.
Nasdaq, S&P 500 Futures Skyrocket After Tamer PPI Data That Confirms Slowing Inflation, Walmart’s Beat-And-Raise Q3
The index futures are solidly higher in premarket trading on Tuesday, as stocks strive to return to winning ways amid lingering hopes of a Fed pause.
Investor Optimism Eases Ahead Of Retail Earnings
The CNN Money Fear and Greed index showed some easing in the overall market sentiment as US stocks dropped to start the week.
The S&P 500 jumped around 5.9% last week, recording its best weekly surge since June.
Dow Dips Over 200 Points, Market Volatility Increases
US stocks closed lower on Monday, as investors digested recent comments from the Federal Reserve officials.
The S&P 500, during the previous week, recorded its biggest weekly percentage surge since late June.
Miniso Group, Monday.com And Other Big Gainers From Monday
U.S. stocks closed lower on Monday, with the Dow Jones dropping more than 200 points. Here is the list of some big stocks recording gains in the previous session.
MacroGenics To Surge 138%? Plus This Analyst Sees $50 For Exact Sciences
BMO Capital boosted the price target on MacroGenics, Inc. (NASDAQ: MGNX) from $5.7 to $16. BMO Capital analyst Etzer Darout upgraded the stock from Market Perform to Outperform. MacroGenics shares gained 3.5% to trade at $6.97 on Monday.
Unity Software, Amazon, Doximity And Other Big Gainers From Friday
U.S. stocks closed higher on Friday, with the Nasdaq Composite jumping more than 200 points. Here is the list of some big stocks recording gains in the previous session.